GSK1292263
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GSK1292263, covering 2017-06-14 to 2018-01-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics [Phase 2]